Emilio Bolla
Biographic Data
| ID | 7647532 |
|---|---|
| NAME | Emilio Bolla |
| GIVEN NAMES | Emilio |
| FAMILY NAME | Bolla |
| SIGNATURE | BOLLA E |
| AFFILIATIONS | Organizzazione Sociopsichiatrica Cantonale |
| ORCID | 0000-0003-1515-9295 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Case Report
Reported results support our hypothesis that long half-lives of cariprazine and its metabolites provide an adequate therapeutic response with a two-times a week administration. In selected patients, cariprazine administered as a "oral long-acting" seems effective in treating acute episodes of illness and in sustaining remission, combining advantages of oral and long-acting injectable antipsychotics concerning therapeutic alliance
Migrant pathways to community mental health centres in Italy
BACKGROUND: Many studies indicate that migrants in western countries have limited access to and low utilization of community mental health centres (CMHCs) despite the high prevalence of mental disorders. AIMS: We aimed to compare migrant pathways to care across four CMHCs located in different Italian provinces and to identify pathway to care predictors. METHODS: Migrants attending the four CMHCs between 1 July 1999 and 31 December 2007 were inclu…
No prominent works on this page.
Migrant pathways to community mental health centres in Italy
BACKGROUND: Many studies indicate that migrants in western countries have limited access to and low utilization of community mental health centres (CMHCs) despite the high prevalence of mental disorders. AIMS: We aimed to compare migrant pathways to care across four CMHCs located in different Italian provinces and to identify pathway to care predictors. METHODS: Migrants attending the four CMHCs between 1 July 1999 and 31 December 2007 were inclu…
Case Report
Reported results support our hypothesis that long half-lives of cariprazine and its metabolites provide an adequate therapeutic response with a two-times a week administration. In selected patients, cariprazine administered as a "oral long-acting" seems effective in treating acute episodes of illness and in sustaining remission, combining advantages of oral and long-acting injectable antipsychotics concerning therapeutic alliance
Medicine (2 works) · Psychiatry (2 works) · Schizophrenia research and treatment (2 works) · Agonist (1 work) · Antipsychotic (1 work) · Bipolar Disorder and Treatment (1 work) · Demography (1 work) · Environmental health (1 work) · Family medicine (1 work) · Gerontology (1 work)